Press Release Date: February 27, 2004
GIC signs as investment advisor to Novoplant GmbH Alexandria VA, February, 27 2004—The GIC Group announced today that it will serve as investment advisor to Novoplant GmbH in order to raise capital and secure
possible joint venture partners for Novoplant's veterinary antibodies development program. Novoplant, a producer and developer of new antibody products for the veterinary market, is currently in the process of expanding its
R&D capacities. Novoplant is attempting to become a key player in the global animal health market, which generates annual revenues of nearly Novoplant, a spin-off from the Institute of Plant Genetics and Crop Plant Research, Gatersleben, Germany, focuses on the veterinary
applications and benefits derived from plant-based antibodies. Novoplant develops antibody products that protect against the pathogens that cause gastrointestinal disorders in animals. Novoplant is launching its new
project as a means to limit food-borne disease pathogens which cause The GIC Group is an advisory and investment service firm which specializes in agribusiness. GIC participates in financial advisory as well as marketing and export
promotion services. GIC will be overseeing the restructuring, development, and strategic planning for the Novoplant project. For more information contact:
Contact: Sean Morrissey, Analyst
(703) 684-1366
Rick Gilmore, President/CEO, The GIC Group,
or Sean Morrissey, Analyst, The GIC Group, research1@gicgroup.com
Telephone: (703) 684-1366